168 related articles for article (PubMed ID: 24571671)
21. [Analgesic efficacy of topical lidocaine for vaso-occlusive crisis in children with sickle cell disease].
Rasolofo J; Poncelet M; Rousseau V; Marec-Berard P
Arch Pediatr; 2013 Jul; 20(7):762-7. PubMed ID: 23731603
[TBL] [Abstract][Full Text] [Related]
22. Pain management trend of vaso-occulsive crisis (VOC) at a community hospital emergency department (ED) for patients with sickle cell disease.
Inoue S; Khan I; Mushtaq R; Sanikommu SR; Mbeumo C; LaChance J; Roebuck M
Ann Hematol; 2016 Jan; 95(2):221-5. PubMed ID: 26611852
[TBL] [Abstract][Full Text] [Related]
23. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
García-Morin M; López-Sangüos C; Vázquez P; Alvárez T; Marañón R; Huerta J; Cela E
Hemoglobin; 2016 Nov; 40(6):388-391. PubMed ID: 28361592
[TBL] [Abstract][Full Text] [Related]
24. Clinical practice guideline improves the treatment of sickle cell disease vasoocclusive pain.
Morrissey LK; Shea JO; Kalish LA; Weiner DL; Branowicki P; Heeney MM
Pediatr Blood Cancer; 2009 Mar; 52(3):369-72. PubMed ID: 19023890
[TBL] [Abstract][Full Text] [Related]
25. Intravenous magnesium sulfate for vaso-occlusive episodes in sickle cell disease.
Goldman RD; Mounstephen W; Kirby-Allen M; Friedman JN
Pediatrics; 2013 Dec; 132(6):e1634-41. PubMed ID: 24276838
[TBL] [Abstract][Full Text] [Related]
26. Intranasal diamorphine for acute sickle cell pain.
Telfer P; Criddle J; Sandell J; Davies F; Morrison I; Challands J
Arch Dis Child; 2009 Dec; 94(12):979-80. PubMed ID: 19321506
[TBL] [Abstract][Full Text] [Related]
27. How French paediatric emergency departments manage painful vaso-occlusive episodes in sickle cell disease patients.
Galeotti C; Courtois E; Carbajal R
Acta Paediatr; 2014 Dec; 103(12):e548-54. PubMed ID: 25130719
[TBL] [Abstract][Full Text] [Related]
28. Drepa-Opia: A Pilot Study to Determine the Predictive Factors of Morphine Use and Consumption in Hospitalized Adult Patients with Sickle Cell Disease.
Sabrie M; Cannas G; Tazarourte K; Poutrel S; Connes P; Hot A; Renoux C; Fattoum J; Joly P
Hemoglobin; 2018 Jul; 42(4):217-224. PubMed ID: 30604640
[TBL] [Abstract][Full Text] [Related]
29. Does e-pain plan improve management of sickle cell disease associated vaso-occlusive pain crisis? a mixed methods evaluation.
Kato-Lin YC; Krishnamurti L; Padman R; Seltman HJ
Int J Med Inform; 2014 Nov; 83(11):814-24. PubMed ID: 25179666
[TBL] [Abstract][Full Text] [Related]
30. Pain management of children and adolescents with sickle cell disease presenting to the emergency department.
Taha HM; Rehmani RS
Saudi Med J; 2011 Feb; 32(2):152-5. PubMed ID: 21301761
[TBL] [Abstract][Full Text] [Related]
31. Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial.
Badaki-Makun O; Scott JP; Panepinto JA; Casper TC; Hillery CA; Dean JM; Brousseau DC;
Pediatr Blood Cancer; 2014 Jun; 61(6):1049-54. PubMed ID: 24443249
[TBL] [Abstract][Full Text] [Related]
32. Treating sickle cell pain like cancer pain.
Brookoff D; Polomano R
Ann Intern Med; 1992 Mar; 116(5):364-8. PubMed ID: 1736768
[TBL] [Abstract][Full Text] [Related]
33. Tramadol infusion for the pain management in sickle cell disease: a case report.
Erhan E; Inal MT; Aydinok Y; Balkan C; Yegul I
Paediatr Anaesth; 2007 Jan; 17(1):84-6. PubMed ID: 17184440
[TBL] [Abstract][Full Text] [Related]
34. Derivation of a risk assessment tool for emergency department patients with sickle cell disease.
Bernard AW; Lindsell CJ; Venkat A
Emerg Med J; 2008 Oct; 25(10):635-9. PubMed ID: 18843058
[TBL] [Abstract][Full Text] [Related]
35. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis.
Yaster M; Tobin JR; Billett C; Casella JF; Dover G
Pediatrics; 1994 Feb; 93(2):310-5. PubMed ID: 8121746
[TBL] [Abstract][Full Text] [Related]
36. Successful epidural analgesia for a vaso-occlusive crisis of sickle cell disease during pregnancy: a case report.
Verstraete S; Verstraete R
J Anesth; 2012 Oct; 26(5):783-5. PubMed ID: 22573004
[TBL] [Abstract][Full Text] [Related]
37. The effect of magnesium on length of stay for pediatric sickle cell pain crisis.
Brousseau DC; Scott JP; Hillery CA; Panepinto JA
Acad Emerg Med; 2004 Sep; 11(9):968-72. PubMed ID: 15347549
[TBL] [Abstract][Full Text] [Related]
38. A comparison of two regimens of patient-controlled analgesia for children with sickle cell disease.
Trentadue NO; Kachoyeanos MK; Lea G
J Pediatr Nurs; 1998 Feb; 13(1):15-9. PubMed ID: 9503762
[TBL] [Abstract][Full Text] [Related]
39. Tramadol use in pediatric sickle cell disease patients with vaso-occlusive crisis.
Borgerding MP; Absher RK; So TY
World J Clin Pediatr; 2013 Nov; 2(4):65-9. PubMed ID: 25254176
[TBL] [Abstract][Full Text] [Related]
40. Outcomes related to intravenous fluid administration in sickle cell patients during vaso-occlusive crisis.
Gaut D; Jones J; Chen C; Ghafouri S; Leng M; Quinn R
Ann Hematol; 2020 Jun; 99(6):1217-1223. PubMed ID: 32367178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
